CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,304,242 | -19.4% | 111,569 | -7.3% | 0.00% | 0.0% |
| Q2 2023 | $1,618,136 | -20.6% | 120,397 | -2.1% | 0.00% | -33.3% |
| Q1 2023 | $2,038,528 | -11.4% | 122,951 | -0.6% | 0.00% | -25.0% |
| Q4 2022 | $2,301,378 | +47.2% | 123,730 | +1.5% | 0.00% | +33.3% |
| Q3 2022 | $1,563,000 | +78.6% | 121,855 | -2.4% | 0.00% | +200.0% |
| Q2 2022 | $875,000 | -15.4% | 124,821 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $1,034,000 | +12.8% | 124,727 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $917,000 | +30.4% | 135,492 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $703,000 | -8.9% | 132,626 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $772,000 | +13.0% | 134,176 | -9.4% | 0.00% | 0.0% |
| Q1 2021 | $683,000 | +40.2% | 148,178 | +1.7% | 0.00% | 0.0% |
| Q4 2020 | $487,000 | +12.5% | 145,751 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $433,000 | -35.7% | 145,751 | +0.0% | 0.00% | 0.0% |
| Q2 2020 | $673,000 | +20.0% | 145,694 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $561,000 | -0.5% | 145,694 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $564,000 | -29.3% | 150,315 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $798,000 | +39.8% | 150,315 | +1.0% | 0.00% | +100.0% |
| Q2 2019 | $571,000 | -24.8% | 148,765 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $759,000 | +133.5% | 148,765 | -12.0% | 0.00% | +100.0% |
| Q4 2018 | $325,000 | -42.2% | 169,104 | +13.8% | 0.00% | 0.0% |
| Q3 2018 | $562,000 | +21.9% | 148,594 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $461,000 | +45.0% | 147,618 | +10.8% | 0.00% | 0.0% |
| Q1 2018 | $318,000 | -27.9% | 133,262 | +18.2% | 0.00% | 0.0% |
| Q4 2017 | $441,000 | +49.0% | 112,778 | -4.1% | 0.00% | 0.0% |
| Q3 2017 | $296,000 | -15.4% | 117,600 | -7.2% | 0.00% | 0.0% |
| Q2 2017 | $350,000 | +84.2% | 126,700 | -22.0% | 0.00% | – |
| Q1 2016 | $190,000 | -44.4% | 162,381 | +16.3% | 0.00% | -100.0% |
| Q4 2015 | $342,000 | -16.8% | 139,573 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $411,000 | -27.6% | 137,079 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $568,000 | – | 137,579 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |